Brief: Vivos Inc. Achieves Record Growth In IsoPet® Animal Cancer Treatments In Q1 2025
23/04/2025 13:33
April 23 (Reuters) - Vivos Inc RDGL.PK: VIVOS INC. ACHIEVES RECORD GROWTH IN ISOPET® ANIMAL CANCER TREATMENTS IN Q1 2025 Source text: ID:nGNX1TSGC6 Further company coverage: RDGL.PK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vivos
See all newsBrief: Vivos Inc. Announces Progress Toward FDA Investigational Device Exemption (Ide) Submission
Brief: Vivos Inc. Strengthens Strategic Collaboration With Exubrion Therapeutics
Brief: Vivos Inc. Retains Top FDA Regulatory Expert Dr. John J. Smith, M.D., J.D., To Support Ide Submission For Radiogel®
Brief: Vivos Board Authorizes To Establish A Corporate Entity In India
Brief: Vivos Inc. Achieves Record Growth In IsoPet® Animal Cancer Treatments In Q1 2025